Machine Learning Approach to Standard Clinical and Biochemical Parameters for Prediction of Pathological Transcranial Doppler in Pediatric Sickle Cell Disease
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Clinical Neuroimaging
- Vol. 3 (1)
Abstract
Background: Children with sickle cell disease (SCD) are at increased risk of cerebrovascular complications, with elevated Transcranial Doppler (TCD) velocities predicting stroke. Reliable laboratory correlates of pathological TCD remain uncertain. This study applied machine learning (ML) to identify hematologic and biochemical predictors of abnormal TCD velocities in pediatric SCD. Methods: We conducted a retrospective analysis of 134 children with SCD (HbSS, HbSβ 0 , HbSβ + , HbSC) followed between 2015 and 2024. A Gradient Boosting Binary Classification model (H2O framework) was trained using demographic, hematologic, biochemical, and treatment variables. Model performance was evaluated using five‐fold stratified cross‐validation, assessed by the area under the receiver operating characteristic curve (AUC) and the precision–recall curve (AUCPR). Results: Across 3190 patient‐years, 447 TCD examinations were analyzed, of which 45 (10.1%) showed conditional or abnormal velocities (≥170 cm/s). The optimized model achieved an AUC of 0.776 and an AUCPR of 0.360, indicating moderate discriminative ability. Reticulocyte and neutrophil counts, hemoglobin, fetal hemoglobin, platelet count, and age were strong predictors, while ongoing therapy showed a protective effect. Conclusions: ML models offer an interpretable, exploratory framework to investigate associations with TCD findings in pediatric SCD, supporting hypothesis generation within guideline‐based care. The absence of systematic Internal Carotid Artery velocity assessment represents an important limitation of this analysis.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Exploring machine learning algorithms in sickle cell disease patient data: A systematic reviewPLOS ONE, 2024
- Genetic Variation and Sickle Cell Disease SeverityJAMA Network Open, 2023
- Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionThe Lancet Haematology, 2023
- Relationship between hemoglobin, hemolysis, and transcranial Doppler velocities in children with sickle cell disease: Results from a long‐term natural history study in Italy in the era of multimodal therapyEuropean Journal of Haematology, 2023
- American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adultsBlood Advances, 2020
- Correlating transcranial arterial Doppler velocities with haematologic parameters and haemolytic indices of Nigerian children with sickle cell anaemiaUltrasound, 2019
- Big Data and Machine Learning in Health CareJAMA, 2018
- Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialThe Lancet, 2016
- Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhoodOrphanet Journal of Rare Diseases, 2013
- Effect of transfusion therapy on transcranial doppler ultrasonography velocities in children with sickle cell diseasePediatric Blood & Cancer, 2010